Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Antidiuretic Hormone (ADH) Market by Type (Intravenous Injection, Intramuscular Injection, Subcutaneous Injection), By Application (Anti-Diuretic Hormone Deficiency, Vasodilatory Shock, Gastrointestinal Bleeding, Ventricular Tachycardia & Fibrillation) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Antidiuretic Hormone (ADH) Market by Type (Intravenous Injection, Intramuscular Injection, Subcutaneous Injection), By Application (Anti-Diuretic Hormone Deficiency, Vasodilatory Shock, Gastrointestinal Bleeding, Ventricular Tachycardia & Fibrillation) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 131891 3300 Pharma & Healthcare 377 235 Pages 4.9 (47)

Market Overview:

The global antidiuretic hormone (ADH) market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of diabetes and other chronic diseases, rising geriatric population, and technological advancements in ADH therapies. However, the high cost of treatment is likely to restrain the growth of this market during the forecast period. Based on type, the global ADH market is segmented into intravenous injection, intramuscular injection, and subcutaneous injection. The intravenous injection segment is expected to account for a major share of the global ADH market in 2018 owing to its ease of use and better patient compliance as compared to other types of injections. By application, anti-diuretic hormone deficiency accounts for a major share of the global ADH market owing to its high prevalence across different regions worldwide.

Global Antidiuretic Hormone (ADH) Industry Outlook

Product Definition:

A hormone that is produced by the pituitary gland and that regulates the amount of water in the body by affecting urine production. Antidiuretic hormone (ADH) is important because it helps to maintain blood pressure and fluid balance in the body.

Intravenous Injection:

Intravenous injection is a medical procedure wherein the drug or medication is administered into the vein of the patient. The IV medications are preferred over oral medications because they bypass gastrointestinal system and reach to the blood stream directly.

  Intravenous Injection (IVI) has become an integral part of modern healthcare, it's usage.

Intramuscular Injection:

Intramuscular injection is a method of delivering a drug into the muscle. Intra muscular or intramuscular means that the drug is injected directly into muscle tissue. The most common use of this technique in ADH treatment involves administration of dextrose 5% in water (D5W), which is used to treat low blood sugar (hypoglycemia).

Application Insights:

The anti-diuretic hormone deficiency segment dominated the global market in 2017 and is expected to witness the fastest growth over the forecast period. The rising prevalence of diabetes has led to an increase in cases of ADH deficiency, which results in water retention and electrolyte imbalance, leading to neurological symptoms such as confusion, headache and vision changes.

Vasodilatory shock is another major application for antidiuretic hormones. It is a rare condition characterized by low blood pressure due to a loss of response from the body¢â‚¬â„¢s natural defense mechanisms against hypovolemic conditions such as inadequate fluid intake or increased excretion of urine. Symptoms include pale skin with blue veins at rest, cold sweats at night time along with mental dullness and anxiety if not treated on time.

Regional Analysis:

North America dominated the global market in 2017. The growth is majorly attributed to the presence of key players, such as Pfizer Inc.; Merck & Co., Inc.; and sanofi. These companies are engaged in extensive R&D activities for new product development and approval. Moreover, increasing prevalence of diabetes is also expected to fuel market growth over the forecast period. For instance, according to CDC estimates published in MMWR Weekly on July 27th 2018, there were 29 million adults with diagnosed diabetes in U.S., which represents 7% of population aged 20 years and above (age-adjusted).

Growth Factors:

  • Increasing incidence of diabetes: The increasing incidence of diabetes is one of the major growth drivers for the antidiuretic hormone market. Diabetes is a condition that results in high levels of blood sugar and can damage many parts of the body, including the eyes, kidneys, nerves, and heart. People with diabetes are at risk for developing various complications such as nerve damage (neuropathy), kidney disease (nephropathy), and eye problems such as cataracts and glaucoma. Diabetic neuropathy is a common complication caused by nerve damage in people with diabetes. It affects up to 60%–70% of people who have had diabetes for 10 years or more2. Rising geriatric population: The geriatric population is another key factor driving the growth of the antidiuretic hormone market worldwide3. Unmet medical needs: There are several unmet medical needs in this market that offer lucrative opportunities to players4 Increased awareness about ADH therapy: There has been an increase in awareness about ADH therapy among physicians and patients alike5 Technological advancements: Technological advancements have led to better diagnosis rates and treatment options for patients suffering from conditions related to ADH deficiency

Scope Of The Report

Report Attributes

Report Details

Report Title

Antidiuretic Hormone (ADH) Market Research Report

By Type

Intravenous Injection, Intramuscular Injection, Subcutaneous Injection

By Application

Anti-Diuretic Hormone Deficiency, Vasodilatory Shock, Gastrointestinal Bleeding, Ventricular Tachycardia & Fibrillation

By Companies

Novartis, Pfizer, Fresenius Kabi, Par Pharmaceutical, Ferring Pharmaceuticals, Astellas Pharma, Shanghai Soho-Yiming Pharmaceuticals

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Antidiuretic Hormone (ADH) Market Report Segments:

The global Antidiuretic Hormone (ADH) market is segmented on the basis of:


Intravenous Injection, Intramuscular Injection, Subcutaneous Injection

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Anti-Diuretic Hormone Deficiency, Vasodilatory Shock, Gastrointestinal Bleeding, Ventricular Tachycardia & Fibrillation

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Novartis
  2. Pfizer
  3. Fresenius Kabi
  4. Par Pharmaceutical
  5. Ferring Pharmaceuticals
  6. Astellas Pharma
  7. Shanghai Soho-Yiming Pharmaceuticals

Global Antidiuretic Hormone (ADH) Market Overview

Highlights of The Antidiuretic Hormone (ADH) Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Intravenous Injection
    2. Intramuscular Injection
    3. Subcutaneous Injection
  1. By Application:

    1. Anti-Diuretic Hormone Deficiency
    2. Vasodilatory Shock
    3. Gastrointestinal Bleeding
    4. Ventricular Tachycardia & Fibrillation
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Antidiuretic Hormone (ADH) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Antidiuretic Hormone (ADH) Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Antidiuretic hormone (ADH) is a hormone that helps the body conserve water. It is produced in the hypothalamus and released into the blood stream when it detects a decrease in blood volume. ADH then travels to various parts of the body, including the kidneys, where it increases urine production.

Some of the key players operating in the antidiuretic hormone (adh) market are Novartis, Pfizer, Fresenius Kabi, Par Pharmaceutical, Ferring Pharmaceuticals, Astellas Pharma, Shanghai Soho-Yiming Pharmaceuticals.

The antidiuretic hormone (adh) market is expected to grow at a compound annual growth rate of 5.8%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Antidiuretic Hormone (ADH) Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Antidiuretic Hormone (ADH) Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Antidiuretic Hormone (ADH) Market - Supply Chain
   4.5. Global Antidiuretic Hormone (ADH) Market Forecast
      4.5.1. Antidiuretic Hormone (ADH) Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Antidiuretic Hormone (ADH) Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Antidiuretic Hormone (ADH) Market Absolute $ Opportunity

5. Global Antidiuretic Hormone (ADH) Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Type
      5.3.1. Intravenous Injection
      5.3.2. Intramuscular Injection
      5.3.3. Subcutaneous Injection
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Antidiuretic Hormone (ADH) Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Application
      6.3.1. Anti-Diuretic Hormone Deficiency
      6.3.2. Vasodilatory Shock
      6.3.3. Gastrointestinal Bleeding
      6.3.4. Ventricular Tachycardia & Fibrillation
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Antidiuretic Hormone (ADH) Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Antidiuretic Hormone (ADH) Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Antidiuretic Hormone (ADH) Demand Share Forecast, 2019-2029

9. North America Antidiuretic Hormone (ADH) Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Application
      9.4.1. Anti-Diuretic Hormone Deficiency
      9.4.2. Vasodilatory Shock
      9.4.3. Gastrointestinal Bleeding
      9.4.4. Ventricular Tachycardia & Fibrillation
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Type
      9.7.1. Intravenous Injection
      9.7.2. Intramuscular Injection
      9.7.3. Subcutaneous Injection
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Antidiuretic Hormone (ADH) Demand Share Forecast, 2019-2029

10. Latin America Antidiuretic Hormone (ADH) Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Application
      10.4.1. Anti-Diuretic Hormone Deficiency
      10.4.2. Vasodilatory Shock
      10.4.3. Gastrointestinal Bleeding
      10.4.4. Ventricular Tachycardia & Fibrillation
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Type
      10.7.1. Intravenous Injection
      10.7.2. Intramuscular Injection
      10.7.3. Subcutaneous Injection
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Antidiuretic Hormone (ADH) Demand Share Forecast, 2019-2029

11. Europe Antidiuretic Hormone (ADH) Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Application
      11.4.1. Anti-Diuretic Hormone Deficiency
      11.4.2. Vasodilatory Shock
      11.4.3. Gastrointestinal Bleeding
      11.4.4. Ventricular Tachycardia & Fibrillation
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Type
      11.7.1. Intravenous Injection
      11.7.2. Intramuscular Injection
      11.7.3. Subcutaneous Injection
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Antidiuretic Hormone (ADH) Demand Share, 2019-2029

12. Asia Pacific Antidiuretic Hormone (ADH) Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Application
      12.4.1. Anti-Diuretic Hormone Deficiency
      12.4.2. Vasodilatory Shock
      12.4.3. Gastrointestinal Bleeding
      12.4.4. Ventricular Tachycardia & Fibrillation
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Type
      12.7.1. Intravenous Injection
      12.7.2. Intramuscular Injection
      12.7.3. Subcutaneous Injection
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Antidiuretic Hormone (ADH) Demand Share, 2019-2029

13. Middle East & Africa Antidiuretic Hormone (ADH) Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Application
      13.4.1. Anti-Diuretic Hormone Deficiency
      13.4.2. Vasodilatory Shock
      13.4.3. Gastrointestinal Bleeding
      13.4.4. Ventricular Tachycardia & Fibrillation
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Antidiuretic Hormone (ADH) Market Size and Volume Forecast by Type
      13.7.1. Intravenous Injection
      13.7.2. Intramuscular Injection
      13.7.3. Subcutaneous Injection
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Antidiuretic Hormone (ADH) Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Antidiuretic Hormone (ADH) Market: Market Share Analysis
   14.2. Antidiuretic Hormone (ADH) Distributors and Customers
   14.3. Antidiuretic Hormone (ADH) Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Novartis Overview Financials Developments Strategic Outlook
      14.4.2. Pfizer Overview Financials Developments Strategic Outlook
      14.4.3. Fresenius Kabi Overview Financials Developments Strategic Outlook
      14.4.4. Par Pharmaceutical Overview Financials Developments Strategic Outlook
      14.4.5. Ferring Pharmaceuticals Overview Financials Developments Strategic Outlook
      14.4.6. Astellas Pharma Overview Financials Developments Strategic Outlook
      14.4.7. Shanghai Soho-Yiming Pharmaceuticals Overview Financials Developments Strategic Outlook
      14.4.8. COMPANY8 Overview Financials Developments Strategic Outlook
      14.4.9. COMPANY9 Overview Financials Developments Strategic Outlook
      14.4.10. COMPANY 10 Overview Financials Developments Strategic Outlook
      14.4.11. COMPANY 11 Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us